When asked about the oncological risk related to BRCA1/2 pathogenic variants, 135 (65.5%) women answered that hormonal contraception increases the risk of breast cancer and 23 (11.2%) that it increases the risk of ovarian cancer (Figure 2A). Here, BRCA1 is linked to breast carcinoma.